{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:37Z","timestamp":1761129577695,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.genhosppsych.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:22:48Z","timestamp":1542198168000},"page":"50-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of direct-acting antiviral drugs for chronic hepatitis C on mood: Preliminary results from a longitudinal study"],"prefix":"10.1016","volume":"56","author":[{"given":"Gioia","family":"Mura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9474-0995","authenticated-orcid":false,"given":"Luchino","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaraffaela","family":"Manca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Preti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Onali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro Giovanni","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2018.10.008_bb0005","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.genhosppsych.2018.10.008_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1499-3872(17)60044-4","article-title":"Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals","volume":"16","author":"Huang","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.genhosppsych.2018.10.008_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.genhosppsych.2018.10.008_bb0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.genhosppsych.2018.10.008_bb0025","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.genhosppsych.2018.10.008_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1745-0179-3-22","article-title":"Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy","volume":"3","author":"Carta","year":"2007","journal-title":"Clin Pract Epidemol Ment Health"},{"issue":"1","key":"10.1016\/j.genhosppsych.2018.10.008_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/jir.2012.0060","article-title":"Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis","volume":"33","author":"Dell'Osso","year":"2013","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"10.1016\/j.genhosppsych.2018.10.008_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpsychores.2014.05.008","article-title":"Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection","volume":"77","author":"Mahajan","year":"2014","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.genhosppsych.2018.10.008_bb0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","article-title":"Interferon alpha (IFNalpha) and psychiatric syndromes: a review","volume":"26","author":"Schaefer","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2018.10.008_bb0050","doi-asserted-by":"crossref","first-page":"e1026","DOI":"10.1038\/tp.2016.274","article-title":"Recurrence of depressive disorders after interferon-induced depression","volume":"7","author":"Chiu","year":"2017","journal-title":"Transl Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834318304195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834318304195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T08:15:45Z","timestamp":1548317745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834318304195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":10,"alternative-id":["S0163834318304195"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2018.10.008","relation":{},"ISSN":["0163-8343"],"issn-type":[{"type":"print","value":"0163-8343"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of direct-acting antiviral drugs for chronic hepatitis C on mood: Preliminary results from a longitudinal study","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}